Oral Syringes Market Size, Share & Trends Analysis Report By Type (Clear Oral Syringes, Colorful Oral Syringes), By Usage (Reusable Oral Syringes, Single Use Oral Syringes), By End-use (Hospitals, Clinics, Homecare Settings), By Region, And Segment Forecasts, 2025 - 2030

Oral Syringes Market Size & Trends

The global oral syringes market size was valued at USD 742.5 million in 2024 and is expected to grow a CAGR of 6.1% from 2025 to 2030. The increasing number of cancer cases among pediatric patients is significantly driving the growth of the oral syringes market. According to the WHO article published in February 2024, every day, over 1,000 children worldwide receive a cancer diagnosis. Advances in medical treatments have significantly improved survival rates in high-income countries, where more than 80% of children with cancer now survive. However, the picture completely differs in low- and middle-income countries, where survival rates drop to approximately 20%. This difference highlights the need for accessible and precise medication delivery systems, such as oral syringes, which play a critical role in pediatric oncology. Oral syringes are essential for administering liquid chemotherapy drugs and supportive care medications like pain relievers and anti-nausea treatments, especially for young patients who struggle with swallowing pills.

The rising number of surgical procedures in children drives the market's growth. According to the Think Global Health article published in March 2024, globally, an estimated 1.7 billion kids lack access to essential care for surgically curable conditions such as cancers, appendicitis, and congenital abnormalities like cleft lip and palate. This challenge is particularly acute in low- and lower-middle-income countries (LLMICs), where pediatric populations represent a significant portion of the total demographic. Among these, approximately 396 million children under the age of five are unable to access timely and affordable surgical interventions. As efforts to bridge these healthcare gaps intensify, there is a growing emphasis on post-surgical recovery tools like oral syringes, which enable precise and safe administration of liquid medications. The increasing focus on enhancing pediatric care, particularly in underserved regions, is expected to drive significant demand for oral syringes, ensuring better recovery outcomes for children undergoing surgical procedures.

The increasing global pediatric population fuels the growth of the oral syringes market.  According to the World Population Review article published in 2024, there are approximately 2 billion children aged 0 to 14 years worldwide, which is expected to reach a peak of 2.06 billion by 2050. This demographic trend signifies a steady rise in the demand for pediatric healthcare solutions, including oral syringes, indispensable for administering liquid medications to children. Unlike adults, children often face challenges swallowing pills or capsules, making oral syringes a practical and precise method for delivering accurate medicine dosages. Furthermore, the growing awareness of child-specific healthcare needs, combined with the rising prevalence of chronic conditions such as asthma and diabetes among children, has further underscored the importance of safe and reliable medication delivery systems.

Data shows the percentage of the country's population that is 0-14 years of age in 2024

Technological advancements in product design and functionality are significantly driving the growth of the oral syringe market. For instance, in January 2023, bluem introduced its latest product, pre-filled oral gel syringes, offering a more convenient solution for users. Each syringe is pre-filled with 3 ml of bluem Oral Gel, simplifying the application process and enhancing ease of use. These pre-filled syringes are designed with user-friendliness, catering to the growing demand for precise and hassle-free medication delivery systems. Such advancements reflect a broader trend in the market, where technology continually improves the efficiency and accessibility of oral syringes, contributing to their increasing adoption across various healthcare applications.

Market Concentration & Characteristics

The oral syringes market demonstrates a moderate degree of innovation, driven by advancements in design and functionality to improve user convenience and accuracy. Developments such as pre-filled syringes, tamper-proof designs, and the use of eco-friendly materials reflect efforts to enhance usability and address sustainability concerns. While these innovations cater to specific needs, the market largely focuses on incremental improvements rather than groundbreaking technological changes.

Key players in the oral syringes industry, such as Baxter, BD., Medtronic, Comar, and Terumo Medical Corporation, actively engage in strategies like mergers and acquisitions and introduce innovative products to broaden their business offerings and strengthen their market presence.  For instance, in February 2022, Comar, a provider of custom medical devices, announced the acquisition of Automatic Plastics Ltd., a contract manufacturing company.

Regulations play a crucial role in the oral syringes industry by ensuring product safety, accuracy, and reliability. Strict compliance requirements, such as those set by the FDA and EU regulatory bodies, mandate precise dosage measurements, non-toxic materials, and user-friendly designs to meet healthcare standards. While these regulations ensure high-quality products, they also increase manufacturing costs and create barriers for smaller players. However, adherence to regulatory standards enhances consumer trust, driving demand for certified and reliable oral syringes.

There are no direct substitutes. The indirect product substitutes include alternative methods for administering liquid medications. These include dosage cups, droppers, and oral dispensers, often used depending on the patient’s needs and the specific medication. For children, liquid medications can also be administered using measuring spoons or specialized drinkable liquid forms.

The market is experiencing significant regional expansion, driven by increasing healthcare needs and growing awareness about precise medication administration. In North America and Europe, the demand is fueled by well-established healthcare systems focusing on pediatric and elderly care. Meanwhile, the Asia-Pacific region is witnessing rapid growth due to rising healthcare access, a growing population, and the increasing prevalence of chronic diseases.

Type Insights

The clear oral syringes segment held the largest share of 62.9% in 2024. The increase in chronic health awareness and the technological advancements in syringes drive the segment's growth. Moreover, key manufacturers offer advanced products such as the Terumo Syringe 60cc/mL (Catheter Tip), which features clear, bold scale markings that ensure accurate dosage control. Its ultra-clear barrel aids in precise measurement, while an integrated plunger stop prevents accidental removal of the plunger. The syringe is latex-free and comes in tamper-evident packaging, ensuring more excellent protection of the sterile contents. Additionally, Comar, LLC provides clear oral syringes designed for accuracy and safety. These syringes feature a two-piece design with a patented wiper system, eliminating small rubber parts and reducing contamination risks. Available in sizes ranging from 0.5 mL to 20 mL, they are made from medical-grade polyethylene and polypropylene, ensuring they are silicone-free and latex-free.

The colorful oral syringes segment is expected to grow during the forecast period. The increasing prevalence of cancer in the pediatric population and technological advancements drive the market's growth. Manufacturers offer various innovative products for the colorful oral syringes segment, designed to enhance safety, accuracy, and ease of use in medication delivery. For instance, Comar, LLC offers customizable oral syringes with various plunger colors, including yellow, orange, red, purple, blue, light green, dark green, and turquoise, paired with clear or amber barrels. These syringes are designed to ensure precise and accurate medication delivery, making them suitable for healthcare applications where visibility and safety are paramount. Similarly, Unicat provides the Colored Oral Syringe, Wide Tip, 3 ml + Cap, and a non-sterile syringe for administering oral medicines or liquids. The syringe barrel is colored to differentiate it from other syringes easily and is designed exclusively for enteral administration. These syringes offer a practical solution for oral medication administration, emphasizing clear identification and effective use in various healthcare settings.

Usage Insights

The reusable oral syringes segment held the largest share of 50.1% in 2024. The increased prevalence of chronic diseases and technologically advanced products offered by the manufacturer drive the segment's growth. For instance, Medicina provides several options, including the 1ml, 2.5ml, 5ml, 10ml, and 20ml Reusable Oral Tip Syringes. These syringes are designed for accurate medication delivery and can be reused after proper cleaning and sterilization, making them a sustainable option in healthcare settings. Similarly, John Preston & Co (Belfast) Ltd offers the ENFIT 3 ml Oral Enteral Reusable Syringes in boxes of 100. These syringes are designed for enteral administration and are reusable, promoting efficiency and reducing waste in clinical environments. Both manufacturers cater to the growing demand for reusable syringes that provide reliable performance and environmental benefits in oral medication delivery.

The disposable oral syringes segment is expected to grow during the forecast period. Increasing cancer cases among pediatric patients and technological advancements drive the market's growth. The healthcare industry increasingly embraces eco-conscious solutions to minimize environmental impact, particularly in disposable oral syringes. As part of this shift, manufacturers are exploring using biodegradable materials and implementing recycling initiatives. For instance, in January 2023, CosmoLab introduced biodegradable 3ml syringes from plant-based substances designed to decompose within 400 days. This significantly reduces environmental pollution compared to traditional syringes, which can take up to 450 years to break down. Upon decomposition, these syringes break down into carbon dioxide, water, and biomass, making them a more sustainable option in the healthcare sector. This trend reflects a growing commitment to sustainability as the demand for environmentally friendly medical products rises.

End-use Insights

The hospitals segment held the most significant share of 56.3% in 2024, driven by the increasing demand for precise and reliable medication delivery in healthcare settings. Hospitals, particularly those providing pediatric and neonatal care, require high-quality oral syringes for accurate dosage and safe administration of liquid medications. As healthcare facilities manage a growing number of hospitalized patients, particularly those with chronic illnesses, respiratory infections like Respiratory Syncytial Virus (RSV), or children under one year of age, the need for efficient, user-friendly syringes becomes more pronounced. According to the CDC article published in August 2024, RSV is responsible for 58,000 to 80,000 hospitalizations annually in children under five in the U.S., with hospitalization rates significantly higher among infants. This emphasizes the rising demand for oral syringes designed to provide accurate dosing, minimize the risk of errors, and improve patient outcomes. Furthermore, innovations in syringe design, such as tamper-evident packaging and ergonomically designed plungers, contribute to more excellent safety and ease of use, driving adoption within hospitals.

The homecare settings segment is expected to grow during the forecast period. The key growth driver is the increasing prevalence of chronic diseases requiring long-term medication management. According to the article BJGP Open published in November 2024, in France alone, 40% of individuals over 16—approximately 20 million report having at least one chronic condition requiring extended treatment at home. However, compliance with such treatments is estimated to be only 50% on average, highlighting significant challenges in medication adherence. Oral syringes offer precise and controlled dosing, improving medication adherence in home care settings. Their calibrated and user-friendly designs ensure accurate and easy administration of liquid medications. Additionally, innovations like tamper-evident packaging and biodegradable materials further expand the market by enhancing safety and sustainability in home-based care. With the high rates of medication non-adherence, over 50% of patients with chronic diseases report forgetting doses, indicating a growing need for tools like oral syringes, which can be paired with personalized reminders to improve compliance.

Regional Insights

North America oral syringes market dominated with a share of 40.6% in 2024. The oral syringes industry exhibits consistent growth owing to several factors, including the increasing prevalence of chronic diseases, technological advancements, and rising pediatric cancer cases. According to the National Cancer Institute article published in August 2024, it is estimated that 14,910 children and adolescents aged 0 to 19 will be diagnosed with cancer in the U.S. in 2024, with 1,590 fatalities expected. Among younger children (ages 0 to 14), approximately 9,620 cases of cancer and 1,040 deaths are projected. These alarming statistics emphasize the critical need for precise medication administration in pediatric oncology. Oral syringes are vital in ensuring accurate and safe delivery of liquid medications for managing treatment side effects and supportive care.

U.S. Oral Syringes Market Trends

The U.S. oral syringes market has a pivotal role in the market. The rising respiratory cases and increasing cancer cases in the pediatric population drive the market growth. According to the American Lung Association article published in September 2024, in the U.S., over 35 million individuals live with chronic lung conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD). These patients often require long-term treatment involving liquid medications, making oral syringes essential for accurate and controlled administration. Ensuring precise dosing and supporting adherence to prescribed therapies, oral syringes play a vital role in managing these respiratory conditions in both clinical and homecare settings.

Europe Oral Syringes Market Trends

The European oral syringes market is projected to experience growth during the forecast period, driven by an increasing prevalence of cancer diseases among the pediatric population and growing awareness among the population. According to the European Commission article published in December 2023, in Europe, cancer incidence among children and adolescents aged 0 to 19 has risen, with an estimated 14,000 new cases and over 2,100 deaths reported in 2022. Managing these conditions often involves liquid medications, necessitating precise and safe administration tools. Oral syringes are increasingly critical in pediatric oncology care, offering accurate dosing and ease of use to support effective treatment and improve patient outcomes.

The UK oral syringes market has been growing in recent years due to the increasing prevalence of cancer conditions among the pediatric population and government initiatives driving the growth of the oral syringes industry. According to the digital.nhs article published in May 2024, In the UK, approximately 3,755 young individuals under 25 are diagnosed with cancer annually, including 1,645 cases in children under 14 and 2,110 among teenagers and young adults aged 15-24. This demographic's increasing need for accurate medication administration has amplified the demand for oral syringes. Their precision and user-friendly design make them essential tools for supporting cancer treatment regimens, particularly for liquid medications in pediatric and young adult patients.

The France oral syringes market is anticipated to witness significant growth during the forecast period. The increasing incidence of respiratory diseases and the rising cancer cases among the pediatric population drive the growth of the oral syringes industry. According to the Institute Curie report, in November 2023, in France, cancer affects approximately 1 in 440 children before they reach the age of 15. This alarming prevalence underscores the importance of precise and reliable medication delivery systems, such as oral syringes, to support pediatric cancer treatments. The demand for these syringes is growing as they ensure accurate dosing of liquid medications, making them vital for managing complex treatment regimens in young patients.

Germany's oral syringes market has grown over the forecast period. A rising prevalence of respiratory cases and ongoing technological advancements fuel the market's growth.  According to the NCBI article published in August 2024, RSV-related outpatient consultations have substantially impacted Germany, ranging between 1.3 million and 3.9 million cases per season from 2014/2015 to 2022/2023 across all age groups. Notably, adults aged 60 and above accounted for 13% of these consultations. The growing prevalence of RSV underscores the demand for precise medication administration tools like oral syringes, which ensure accurate dosing and ease of use. This trend positions oral syringes as vital in managing respiratory illnesses in outpatient settings, especially for vulnerable populations.

Asia Pacific Oral Syringes Market Trends

Asia Pacific oral syringes market is expected to witness the fastest growth over the forecast period due to rising cancer cases among children and increased awareness. According to the WHO article published in February 2024, each year, around 61,000 new cases of childhood cancer are diagnosed in the WHO South-East Asia Region, with nearly 45% of these children succumbing to the disease. Alarmingly, estimates suggest that approximately half of all new cases go undiagnosed in this region. This growing concern underscores the importance of improving healthcare systems and treatment management, especially in countries with limited healthcare resources. As childhood cancer cases increase, the demand for precise and reliable drug administration tools, such as oral syringes, is expected to rise.

China oral syringes market has grown significantly over the forecast period. Increasing cancer cases among children and the rising respiratory cases drive the growth of the oral syringes industry. According to the JAMA Network article published in October 2024, in China, approximately 40,000 new cases of childhood cancer are diagnosed each year, highlighting a significant healthcare challenge. With increasing cancer diagnoses, the need for efficient and accurate medication delivery becomes even more critical, especially in pediatric care.

Japan oral syringes market is expected to witness intense competition. The increasing prevalence of respiratory diseases and the rising cancer cases among the pediatric population drive the growth of the market. According to the Dove Medical Press Ltd article published in March 2024, in Japan, approximately 200,000 individuals are diagnosed with Chronic Obstructive Pulmonary Disease (COPD), reflecting a prevalence rate of 0.2% to 0.4% according to a survey by the Japanese Ministry of Health, Labour, and Welfare. As COPD management often involves long-term medication regimens, oral syringes play a critical role in ensuring accurate and consistent medication delivery. The demand for oral syringes in Japan is likely to rise in response to the growing need for precise dosing in treating chronic respiratory conditions like COPD.

Latin America Oral Syringes Market Trends

The region's developing healthcare infrastructure drives Latin America's oral syringes market. Rising respiratory cases and increasing cancer cases in pediatric population drives the growth of the market. According to the NCBI article published in March 2024, in Latin America, the incidence rate of cancer among children aged 0-14 years is estimated at 135.1 per million, based on data from general cancer registries. This increasing number of childhood cancer cases creates a growing demand for precise medication management tools, such as oral syringes, to support the treatment of young patients.

Brazil oral syringes market has one of Latin America's most advanced healthcare systems, positioning it as a leading regional oral syringe market. Increasing cancer incidence in children and the growing respiratory conditions among the population drive market growth. According to the NCBI article published in March 2024, in Brazil, the National Cancer Institute (INCA) estimates that approximately 7,930 new childhood and adolescent cancer cases will be diagnosed annually from 2023-2025. This growing incidence of pediatric cancer highlights the increasing need for accurate and efficient medication administration. Oral syringes play a crucial role in delivering precise doses of medication for young patients undergoing cancer treatment.

MEA Oral Syringes Market Trends

The Middle East & Africa oral syringes market is experiencing significant growth, driven by the increasing prevalence of respiratory diseases and conditions, and technological advancements. According to the WHO article published in October 2024, Middle East Respiratory Syndrome (MERS), caused by the MERS-CoV virus, is a severe respiratory infection with a high mortality rate of approximately 36%. The prevalence of MERS in the Middle East and Africa (MEA) region has led to increased demand for healthcare solutions, including treatments that require precise medication delivery, such as oral syringes.

The Kuwait oral syringes market is experiencing growth over the forecast period. Rising respiratory diseases mortality and increasing pediatric cases in children drives the growth of the market. According to the WHO article published in May 2024, in Kuwait, the death rate from lower respiratory infections in 2021 was recorded at 8.4 deaths per 100,000 population. This highlights the ongoing challenges posed by respiratory diseases in the country. As healthcare systems continue to address these conditions, the demand for precise medication delivery systems, such as oral syringes, is rising. Oral syringes play a crucial role in the accurate administration of liquid medications, especially for managing respiratory infections and other chronic conditions.

Key Oral Syringes Company Insights

Companies are focusing on strategic initiatives, such as introducing novel products through customization according to consumers’ needs, partnerships, collaborations, and mergers & acquisitions, to expand their product portfolio and extend leadership positions in the field of cardiology field. Moreover, the competition between key players will intensify in the coming years as they focus more on geographical expansion, strategic collaborations, and partnerships through mergers & acquisitions.

Recent Developments

• In August 2024, elm-plastic expanded its Short Form syringe collection with the introduction of a new 1.5ml oral syringe. This addition enhances the company's range, offering a more versatile solution for precise medication administration.

• In March 2024, BD ramped up domestic production of syringes at its facilities in Nebraska and Connecticut to meet customer demand better. This effort addresses the growing need for syringes across various healthcare applications, providing a more reliable and efficient supply for patients and healthcare providers.

• In August 2023, The Codan Group successfully acquired the entirety of Eagle NewCo Limited, a UK company specializing in command-and-control solutions, from NEC Software Solutions UK Limited.

Oral Syringes Market Report Scope

Global Oral Syringes Market Report Segmentation

This report forecasts global, regional, and country revenue growth. It provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global oral syringes market report based on type, usage, end-use, and region:

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Clear Oral Syringes

  • Colorful Oral Syringes

• Usage Outlook (Revenue, USD Million, 2018 - 2030)

  • Reusable Oral Syringes

  • Single Use Oral Syringes

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Clinics

  • Homecare Settings

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait